Talk:Subacute sclerosing panencephalitis

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.
	This article is supported by the Neurology task force (assessed as Mid-importance).

Viruses Mid‑importance

	Viruses portal This article is within the scope of WikiProject Viruses, a collaborative effort to improve the coverage of viruses on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.VirusesWikipedia:WikiProject VirusesTemplate:WikiProject Virusesvirus articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Subacute sclerosing panencephalitis.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

note

The section on symptoms sounds dubious (was taken from House MD, which is not an accurate source of medical facts), not sure how it could be changed though. SSPE is really a rare disease. Exdisq13 20:56, 14 April 2007 (UTC)[reply]

Apparent contradiction

I don't see how "it is universally fatal in all occurrences" and "there is a 5% remission rate" can both be true. Eyu100^{(t|fr|Version 1.0 Editorial Team)} 07:47, 2 April 2012 (UTC)[reply]

I don't see how there can be a "50% remission/improvement rate" with treatment "[r]egardless of the stage that the infection is at" if "stage 2...is universally fatal in all occurrences," so I have tagged the article with {{contradict-self}}. 71.163.176.158 (talk) 04:02, 11 February 2015 (UTC)[reply]

It seems that there are two paths that the disease can follow. I can be aggressive and death can occur within three months or it can take between one and three years to cause death, with a 5% remission rate. From what little I've read on the disease, which stage the patient is in influences outcome of the experimental protocols in use today, with stage one having a significantly better survival rate to those who are in stage two and whose outlookis dire. See http://www.ninds.nih.gov/disorders/subacute_panencephalitis/subacute_panencephalitis.htm for some non-technical information on the disease.Wzrd1 (talk) 16:32, 13 March 2015 (UTC)[reply]

Remissions are always temporal and invariably end in the final and fatal relapse. Probably, treatment post stage 1 only results into some temporal improvement, which does not affect prognosis. Ruslik_Zero 19:31, 19 September 2017 (UTC)[reply]

Fatal?

The article is not clear on whether SSPE is universally fatal.--Solomonfromfinland (talk) 13:44, 5 May 2013 (UTC)[reply]